Several N-nitroso compounds induce tumors of the colon, and some induce tumors in other parts of the intestinal tract as weIl. The nitrosamines that induce colon tumors are beta oxidized n-propyl-nitrosamines. These require metabolic activation, as do 1,2-dimethylhydrazine, azomethane, and azoxymethane, another group of colon carcinogens. Several nitrosoalkylureas induce tumors in rat colons after oral administration, although the monoalkylnitrosoureas are fairly unstable and might not be expected to reach the colon. However, monoalkylnitrosoureas are equally effective with the much more stable dialkylnitrosoureas. Although nitrosomethylurea did not induce colon tumors under these conditions, nitrosoethylurea did, together with nitrosodiethylurea and other nitrosoethylalkylureas. Nitroso-n-butyl-, n-amyl-, n-hexyl-urea, and nitrosohydroxyethylurea also induced colon tumors, but the last, like nitrosoethylurea, also induced tumors of the duodenum and ileum. In most of these experiments male rats were more susceptible to induction of intestinal tumors than female rats. An explanation for the differences between these compounds of similar structure might be found in variations in their ability to alkylate DNA in intestinal cells, or in differences in stability of the alkylated product between the compounds. The physical properties of the compounds might also modulate the process of carcinogenesis, however.
INTRODUCTION
Even though relatively few chemical carcinogens induce tumors of the colon in experimental animals, colorectal cancer is among the most common cancers in humans living in industrialized countries, excepting Japan. There are two reasons for studying the chemical induction of cancer at this site: first, because of the need to know about human exposure to carcinogens that might be involved in its etiology, and second, to understand the mechanisms by which cells in these organs are transformed into tumors.
Among the chemicals which have been found to induce colon tumors, but usually not rectal tumors, are several aromatic amines. These include some that are products of pyrolysis of amino acids and proteins (14), 1,2-dimethylhydrazine (1) and its products of oxidation, azomethane and azoxymethane (lo) , and the aglycone of cycasin, methylazoxymethanol acetate (2) . In addition, several N-nitroso compounds, including nitrosomethylurea and nitrosomethylnitroguanidine, have induced colon tumors when injected directly into the colon (1 5). The few nitrosamines that have induced tumors of the colon (Table I) (2-oxopropy1)amine (1 2), nitrosobis-2-hydroxypropylamine, and nitroso-2-hydroxypropyl-2-oxopropylamine (Lijinsky et al, unpublished) . Nitrosamines were active when given to rats orally, which was the route employed for the compounds related to dimethylhydrazine. It is probable that these compounds underwent extensive metabolism prior to the induction of tumors in the colon. Some steps in this metabolic activation were likely to have occurred in the liver, since these compounds induced tumors of the liver and other organs of the rat. On the other hand, the directly acting N-nitroso compounds, such as nitrosoalkylureas, do not require metabolic activation and are also directly acting mutagens and alkylating agents (1 3).
NITROSOALKYLUREAS INDUCING INTESTINAL TUMORS
Some time ago, it was found that nitroso-2-hydroxyethylurea induced tumors of the colon (along with tumors of many other organs) when given by gavage to rats. The incidence of colon tumors was not large (9), but the absence of tumors of this type in untreated control rats suggested that the colon tumors were due to treatment with the nitrosoalkylurea. A subsequent study of the relation between the chemical structure of nitrosoalkylureas and their carcinogenic action revealed that many N-nitroso I98 at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from compounds of this type-but not all-induce tumors of the colon, as well as tumors in the duodenum and ileum. Strangely, none of these compounds, regardless of structure, has induced tumors of the esophagus, although the rat esophagus is extremely sensitive to tumor induction by nitrosamines. Even though more than half of all nitrosamines tested have induced esophageal tumors in rats (3), none of the N-nitroso compounds so far examined has induced tumors of the esophagus in hamsters or guinea pigs, illustrating the strong species specificity of these carcinogens.
A similar specificity of response is seen with the N-nitroso compounds that induce tumors in the intestines of rats, since none of these compunds has given rise to intestinal tumors in hamsters, even though they were given to rats and hamsters by the same route (gavage) and at similar doses. The hamster is not refractory to the carcinogenic effect of those N-nitroso compounds, directly acting or those requiring metabolic activation. Rather, the hamster seems to respond only in certain ways to N-nitroso compounds, regardless of the structure. For example, although the N-nitrosoalkylureas that have been given to rats have induced a variety of tumors, in hamsters they have induced only tumors of the forestomach and hemangiosarcomas of the spleen. No tumors of the colon, duodenum, or ileum were induced by any of these compounds in hamsters, although they are directly acting carcinogens and presumably the lower gastrointestinal tract would be series of receptive organs. The difference in the responses of rats and hamsters to nitrosoalkylureas sheds some doubt on our concept of the mechanism of carcinogenesis by these compounds. Perhaps they do require some type of cell activation that is provided by the rat, but not by the hamster.
Some well-known experiments showed the induction of colon tumors in rats by means of a solution of nitrosomethylurea or nitrosomethylnitroguanidine that was deposited in the colon through the anus. This treatment was followed by various diets to demonstrate the influence of fat as a tumor promotor. These experiments demonstrated the susceptibility of the rat colon to the induction of tumors by nitrosomethylurea (15) . It might be expected, therefore, that oral administration of nitrosomethylurea might allow the colon epithelium to come in contact with some portion of the dose, thus giving rise to tumors. In our experiments, the nitrosoalkylureas were administered in solution in corn oil, in which the compounds are stable, and presumably less readily absorbed than from aqueous solution. Absorption does occur, however, probably through the lymphatic system: 60% of the dose of radiolabeled nitrosomethylurea given to rats is con- Nevertheless, administration of nitrosomethylurea to rats by gavage, to a total dose of 0.8 mmole, induced a high incidence of nervous system and forcstomach tumors, but none in the intestines, including the colon. In contrast, the structurally similar nitrosoethylurea, which is equally readily absorbed and readily metabolized when given to rats by gavage, induced few tumors in the nervous system, but induced tumors in many other organs, including the duodenum, ileum, and colon. The reasons for the large difference in carcinogenic effectiveness in rats between nitrosomethylurea and nitrosoethylurea are not readily apparent, since both are mutagenic in many systems, are similar in stability and in chemical properties, and are effective in inducing skin tumors by painting on mouse skin (3).
An equa! dose of nitroso-2-hydroxyethylurea is even more effective than nitrosoethylurea in inducing tumors of the duodenum, ileum, and colon in rats when given by gavage. Nitrosohydroxyethylurea gives rise to a much higher incidence of tumors in the lower gastrointestinal tract, and to a broad spectrum of tumors in other organs. It might be relevant that nitrosohydroxyethylurea is a much more potent bacterial mutagen than is nitrosoethylurea (6), which is possibly related to the presence of the hydroxyl group. However, even though the methyl ether of nitroso-2-hydroxyethylurea, nitro- --20
15
-somethoxyethylurea, is an equally potent mutagen, which also induces tumors of the colon and of the duodenum when given to rats by gavage, it did not induce tumors of the ileum or jejunum.
A series of nitrosoalkylureas has induced intestinal tumors in rats when given by gavage. The results of these experiments are shown in Table 11 , and show some interesting differences, which .are difficult to explain with present knowledge. The total doses to which the rats were exposed are not very different, but the time-to-death with tumors differed somewhat. Differences in such physical properties as lipid-water partition cannot account for the induction of colon tumors, but not tumors of the duodenum by nitroso-n-butylurea, and tumors of the duodenum and jejunum, but not of the colon, by nitroso-2-phenylethylurea. Nitrosoallylurea induced tumors of the colon in male rats, but not in females. The reasons for the male-female discrepancy are not known, but the discrepancy is not confined to this particular nitrosoalkylurea. However, there are nitrosoalkylureas which induce colon tumors equally in male and female rats.
NITROSODIALKYLUREAS
There is a certqin similarity in the structures of nitrosoalkylureas that induce colon tumors in rats, including nitrosodialkylureas, which are much more stable than nitrosomonoalkylureas, but are still directly acting alkylating agents and directly acting mutagens (6). Nitrosodimethylurea, which is considerably weaker than nitrosomethylurea, took much longer to induce malignant tumors in the nervous systems of rats; like nitrosomethylurea, however, it induced no tumors in the intestinal tract. In contrast, nitrosodiethylurea was as rapidly acting as ni-trosoethylurea, and like the latter, it induced a variety of tumors in the colon, duodenum, and jejunum of rats (Tables I and 11 ). These tumors of the intestines appeared only in male rats, however. The absence of such tumors in female rats cannot be explained by inadequate survival of the females. They died mainly from malignant mammary tumors, but not more than a few weeks earlier, on average, than the males. The analogous nitrosoethylmethylurea produced almost exactly the same pattern of tumors as nitrosodiethylurea, but the rats given nitrosodiethylurea died some weeks earlier, suggesting that the tumors were more easily induced, or progressed more rapidly, than with nitrosoethylmethylurea. The proportion of rats with tumors of the colon, jejunum, and ileum was very similar between the two treatments. Nitrosoethyl-2-hydroxyethylurea also induced tumors of the colon in rats (1 1) in a very similar incidence to nitrosodiethylurea. The median time-to-death of these animals, however, was much longer, by as much as 20 weeks.
Except for the higher incidence of tumors in the nervous system induced by the hydroxyethyl compond, there was little difference in the distribution of tumors induced by the three nitrosoethylalkylureas. It can be concluded, then, that the comparatively small incidence of colon tumors is not due to the early death of the rats from other types of tumor. It seems that the affinity of the nitrosoethylurea structure for certain receptors in some types of cells is a determinant, but the relative affinities in the various target cells remain the same. The sharp difference between the nitrosoethylalkylureas, which induce tumors in the colon and in other parts of the intestines, and the nitrosomethylalkylureas, which are potent carcinogens but do not induce tumors in the intestines, reinforces this probability.
ALKYLATION MECHANISMS IN CARCINOGENESIS
In a homologous series of carcinogens, the methyl compounds are frequently anomalous in behavior. This is certainly true of the N-nitroso compounds, and especially the nitrosoalkylureas discussed here. The overwhelming tendency of the nitrosomethylalkylureas is to induce tumors in the nervous system, but not in the gastrointestinal tract or in the forestomach, which is the first organ they encounter when given by gavage. Most of the higher homologs, including ethyl-, butyl-, amyl-and hexyl-nitrosourea, and h ydrox ye t h yl-and me thox ye t hyl-nitrosourea, readily induce tumors in the gastrointestinal tract, including the colon, jejunum, ileum, and duodenum. However, they produce few, if any, tumors in the nervous system. Physical properties, such as liposolubility and partition coefficients, might seem to play a role, but the properties of nitrosomethylurea and nitrosoethylurea do not differ nearly so much as nitrosodimethylurea differs from nitrosomethylurea. Similarly, in reactivity and stability, nitrosomethylurea and nitrosoethylurea are much more similar than are nitrosomethylurea and nitrosodimethylurea. In chemical stability,. nitrosomonoalkylureas resemble one another much more than they do any nitrosodialkylurea. It must be concluded, therefore, that the organ specificities demonstrated by these nitrosoalkylureas is due not primarily to the decomposition into alkylating agents (which would be alkyldiazonium ions, formed at different rates depending on whether the source was a mono-, di-or trialkylnitrosourea), but to the chemical structure of the nitrosourea and its affinity for some cellular receptor. Identification of these receptors would help in understanding the mechanisms of nitrosoalkylurea carcinogenesis.
The influence of the whole structure of the nitrosourea on organ-specific carcinogenesis is apparent, but difficult to understand. For example, nitroso-2-hydroxyethylurea, its methyl ether and nitroso-2-hydroxyethylethylurea, all induce tumors of the colon in rats, whereas nitroso-2hydroxyethyl-2-chloroethylurea does not. The latter compound does, however, induce a high incidence of liver tumors and tubular cell neoplasms in the rat kidney (8), in which the median survival is much longer than for rats treated with the other hydroxyethylnitrosoureas. None of the nitrosoureas examined in Syrian hamsters has induced tumors of the GI tract, other than in the forestomach; the only other tumors that have appeared in hamsters given nitrosoalkylureas of whatever structure, including mono-, di-and trialkylnitrosoureas, have been hemangiosarcomas of the spleen. The reason for the singular susceptibility of endothelial cells of the hamster spleen to nitrosoalkylureas is an intriguing but unsolved mystery.
A comparison of the effects on the rat GI tract of azoxymethane and nitrosoethylurea does not provide a simple rational explanation for their common action in inducing tumors in the colon. Azoxymethane is generally considered to be a methylating agent (l), which methylates DNA in the colon and in the liver of rats and hamsters (4). Its higher homolog, azoxyethane, can be considered by analogy to be an ethylating agent. It has not, however, induced tumors in the lower GI tract in rats, although it is a powerful carcinogen (1 0 ) . On the other hand, in our studies nitrosomethylurea, which is a methylating agent, has not induced tumors of the intestines, while the ethylating agent nitrosoethylurea has induced tumors in those organs. As discussed above, the nitrosomethylureas have not, in general, induced TOXICOLOGIC PATHOLOGY tumors of the colon, while the analogous nitrosoethylureas have induced those tumors. These patterns suggest that formation of a methylating or an ethylating agent is not the source of the organ-specific carcinogenicity of these compounds (although alkylation might be a step in carcinogenesis). The organ-specific carcinogenicity appears to result from some characteristics of the entire molecule.
ORGAN SPECIFICITY OF N-NITROSO COMPOUNDS
It is not known whether the cbmpounds which induce colon tumors reach the colon by passage through the gut, or whether they act systemically. There is some evidence that part of the action of carcinogens that induce tumors of the colon, and even of the forestomach, is systemic, because tumors of these organs are induced by intraperitoneal or subcutaneous injection of the same compounds that induce those tumors by administration in drinking water or by gavage. Therefore, investigation of the mechanism of action of carcinogens that induce colon tumors is less one of considering their direct action or products of their metabolism, and more a matter of considering why compounds with those structures have an affinity for the colon, as distinct from the kidney, liver, or other organs that are not their targets.
Most of the compounds that induce intestinal tumors have the colon as the main site of tumor formation. Some compounds induce tumors only in the colon, such as azoxymethane, ethylazoxymethane, nitrosobis-(2-oxopropyl)amine (BOP) and nitrosohydroxypropyl-oxopropylamine (HPOP), as well as several of the nitrosoalkylureas. Only one of the compounds, nitrosophenylethylurea, induced tumors in the duodenum and jejunum, but not in the colon of rats. Nitrosooxazolidone is also in this category: it gave rise to tumors in the duodenum, but not in the colon, of Syrian hamsters, and to no tumors in the intestinal tract of rats. These results can be compared to carcinogens other than nitrosoalkylureas, which might require specific metabolic activation provided by the colon mucosa, but not by other parts of the intestinal tract. There is some evidence for this in the work of Fiala with azoxymethane, showing methylation ofDNA in the colon mucosa by products of metabolism of azoxymethane (1). This does not prove that such methylation is specifically related to the induction of tumors in the colon, particularly since methylation of DNA in organs that are not targets of azoxymethane carcinogenesis was not studied. However, Fiala's work demonstrates that there is metabolism in the colon which does not take place with azoxymethane in other organs. The same is likely to be true of BOP and HPOP, that is, there could be specific metabolism in the colon which does not take place in other organs. In the case of BOP, we have shown that DNA methylation by this nitrosamine occurs both in organs in which it induces tumors, and organs in which it does not induce tumors (unpublished). The mechanism by which these compounds induce tumors is far from understood.
In the case of the directly-acting nitrosoalkylureas, the induction of tumors in the colon, as distinct from other parts of the GI tract, is less easily understood. The compounds listed in Table I were all administered orally, the nitrosoalkylureas as twice weekly treatments of rats by gavage. Although all of the nitrosoureas are directly-acting bacterial mutagens, their potencies vary widely within a range of at least two orders of magnitude: from the weakly mutagenic nitrosoethylurea and nitrosodiethylurea to the potent mutagens nitroso-2-phenylethylurea and nitrosohydroxyethylurea (6) . All of these compounds presumably are mutagenic through direct alkylation of the bacterial DNA.
The size and chemical nature of the alkyl group seems to have only a quantitative effect. There is little difference, for example, between nitrosohydroxyethylurea and its ether, nitrosomethoxyethylurea, but there is alarge quantitative difference between nitroso-2-hydroxypropylurea and the much weaker nitroso-3-hydroxypropylurea. It seems logical that nitrosoalkylureas act through bathing of the mucosa of the GI tract by the solutions placed in the stomach (and most of them induce a high incidence of tumors of the forestomach). Therefore, it is not easy to rationalize their common induction of colon tumors, but the failure of many of them to induce tumors in the duodenum, ileum and jejunum, which the solutions enter first. Since many of them do induce tumors in other parts ofthe GI tract, as well as in the colon, this refractoriness to certain nitrosoalkylureas cannot be due to constitutive resistance to this type of compound.
One explanation could be that they remain in the colon a longer time. This is borne out to some extent by the finding that two nitrosodialkylureas, which are much more stable than the corresponding nitrosomonoalkylurgas (nitrosoethylhydroxyethylurea and nitrosohydroxyethylethylurea), induced tumors in the colon, but not in the duodenum, ileum, or jejunum. However, this did not happen with the equally stable compounds, nitrosodiethylurea and nitrosoethylmethylurea. Neither did it occur with nitroso-n-butylurea or nitroso-n-hexylurea. These compounds also induced tumors only in the colon of rats, although they were no more stable (6) than the other nitrosomonoalkylureas, which induced tumors in all parts of the intestinal tract in rats.
The number of animals with intestinal tumors following treatment with any of the nitrosoalkylureas was usually relatively small. Rats frequently died from other types of tumors, which raises the question of competing risks. It does not seem, however, that early death from other causes precludes development of tumors in the colon and other parts of the intestines, since there is a large and somewhat patternless variation in median time-to-death from tumors (Table 11) in rats receiving nitrosoalkylureas (5). Many of the compounds that induce colon tumors in rats have failed to induce tumors in the intestines of Syrian hamsters, when given at comparable doses. Except for nitrosoethylurea, which induced a low incidence of colon tumors, the nitrosoalkylureas restricted their action in hamsters almost entirely to the spleen and forestomach (7) .
CONCLUSION

Examination of some consistent findings in the studies of induction of colon tumors in rats might
suggest ways of exploring the mechanisms of colon carcinogenesis. One result was the higher incidence of colon tumors in male rats than in females, even though in our experiments the males, being larger, .received a smaller dose per unit body weight than the females because the dose per animal was usually the same. There was no case in which the incidence of colon tumors was higher in females than in male rats. Another finding was the failure of any of the nitrosomethylureas to induce colon tumors when given by mouth. This occurred regardless of there being no apparent difference chemically or mutagenically from the corresponding nitrosoethylureas or nitrosohydroxyethylureas. It is conceivable that a minimum molecular size for a nitrosoalkylurea is needed in order for there to be a reaction with the appropriate receptor in the colon cells, and that nitrosomethylureas are too small. However, the induction of tumors in the colon by the methylating compound azoxymethane would tend to refute this argument. It is obvious that much remains to be learned about the chemistry and biochemistry of the colon carcinogens, as well as about the biology of the colon mucosa, before the induction of colon tumors by so special a group of compounds can be understood.
